LONDON--(BUSINESS WIRE)--Imperial Innovations Group plc (AIM: IVO, “Innovations”, “the Group”) has announced the appointment of Dr Paolo Paoletti MD, as Executive Chairman of portfolio company Kesios Therapeutics (“Kesios” or “the Company”), which is developing novel therapeutics for the treatment of multiple myeloma and other cancers.
Help employers find you! Check out all the jobs and post your resume.
